Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Modeling of Intracellular Taurine Levels Associated with Ovarian Cancer Reveals Activation of p53, ERK, mTOR and DNA-Damage-Sensing-Dependent Cell Protection

Nutrients(2024)10.3390/nu16121816Source: DataRank Database

Modeling of Intracellular Taurine Levels Associated with Ovarian Cancer Reveals Activation of p53, ERK, mTOR and DNA-Damage-Sensing-Dependent Cell Protection is a research paper published in Nutrients (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)OA: goldTopics (51)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Sadaf Farsinejad ORCID,Elena Kochetkova ORCID,Tatiana Volpari,Aleksandra Gładych-Macioszek ORCID,Agnieszka Klupczyńska ORCID

Live enrichment

PubMed:38931171

Olipass Corporation

Grant: NIH/NCI R21CA256615

Olipass Corporation

Grant: 2021-01787

Olipass Corporation

Grant: R21CA240219

Olipass Corporation

Grant: CAN 2017/466

Olipass Corporation

Grant: CAN 2017/1015

Olipass Corporation

Grant: 20 0979 PjF

Olipass Corporation

Grant: FO2021-0082

Olipass Corporation

Grant: BA22-094

Olipass Corporation

Grant: LA2022-0075

Olipass Corporation

Grant: RRID SCR_004446

National Institutes of Health

Grant: 5R21CA240219-03

Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resections

National Institutes of Health

Grant: 5R21CA256615-02

High-Resolution Dynamic Imaging of Ovarian Cancer Metastasis Post Chemotherapy

NIH/NCI

Grant: R21CA256615

The Swedish Cancer Society

Grant: CAN 2017/466, CAN 2017/1015, 20 0979 PjF

Kaleidoscope of Hope Ovarian Cancer Research Foundation

Grant: N/A

goldLicense: cc-by

publisherhttps://www.mdpi.com/2072-6643/16/12/1816/pdf?version=1717922514

publisherhttps://www.mdpi.com/2072-6643/16/12/1816/pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11206249

repositoryhttps://durham-repository.worktribe.com/output/2526088

https://doi.org/10.1101/2023.02.24.529893

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciencesTaurineHumansTOR Serine-Threonine KinasesFemaleOvarian NeoplasmsDNA DamageCisplatinTumor Suppressor Protein p53Cell Line, TumorCell ProliferationSignal TransductionGlycolysisExtracellular Signal-Regulated MAP KinasesAntineoplastic Agents

MeSH Terms

TaurineHumansTOR Serine-Threonine KinasesFemaleOvarian NeoplasmsDNA DamageCisplatinTumor Suppressor Protein p53Cell Line, TumorCell ProliferationSignal TransductionGlycolysisExtracellular Signal-Regulated MAP KinasesAntineoplastic Agents

Keywords

ovarian cancer cellscell protectionTaurineAntineoplastic Agentsgrowth suppressionArticlefallopian tube cellsCell Line, TumorHumansExtracellular Signal-Regulated MAP KinasesCell ProliferationOvarian NeoplasmsTOR Serine-Threonine Kinasesgenotoxic stressFemaleCisplatinTumor Suppressor Protein p53Glycolysissignal transductionDNA Damage

Sustainable Development Goals

SDG 3: 3. Good health